Carle F Paul (C F Paul, Carle Paul, C Paul)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 42

Top Topics

Atopic Dermatitis

Top Venues

The British journal of dermatology

The Journal of experimental medicine

Clinical and experimental dermatology

Clinical reviews in allergy & immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Alessia Baldo, Jeremy Di Domizio, Ahmad Yatim, Sophie Vandenberghe-Dürr, Raphael Jenelten, Anissa Fries, Lorenzo Grizzetti, François Kuonen, Carle F Paul, Robert L Modlin, Curdin Conrad, Michel Gilliet
Human neutrophils drive skin autoinflammation by releasing interleukin (IL)-26. The Journal of experimental medicine 221 (5) (2024)
Mark G Lebwohl, Richard Bruce Warren, Howard Sofen, Shinichi Imafuku, Carle F Paul, Jacek Cezary Szepietowski, Lynda Spelman, Thierry Passeron, Eleni Vritzali, Andrew Napoli, Renata M Kisa, Alex Buck, Subhashis Banerjee, Diamant Thaҫi, Andrew Blauvelt
Deucravacitinib in plaque psoriasis: 2-year safety and efficacy results from the phase III POETYK trials. The British journal of dermatology 190 (5) (2024)
Mark Lebwohl, Richard Bruce Warren, Howard Sofen, Shinichi Imafuku, Carle F Paul, Jacek Cezary Szepietowski, Lynda Spelman, Thierry Passeron, Eleni Vritzali, Andrew Napoli, Renata M Kisa, Alex Buck, Subhashis Banerjee, Diamant Thaҫi, Andrew Blauvelt
Deucravacitinib in plaque psoriasis: 2-year safety and efficacy results from the phase 3 poetyk trials. The British journal of dermatology (2024)
Clémence David, Carlos A Arango-Franco, Mihaly Badonyi, Julien Fouchet, Gillian I Rice, Blaise Didry-Barca, Lucie Maisonneuve, Luis Seabra, Robin Kechiche, Cecile Masson, Aurélie Cobat, Laurent Abel, Estelle Talouarn, Vivien Béziat, Caroline Deswarte, Katie Livingstone, Carle F Paul, Gulshan Malik, Alison Ross, Jane Adam, Jo Walsh, T Sathish Kumar, Damien Bonnet, Christine Bodemer, Brigitte Bader-Meunier, Joseph A Marsh, Jean Laurent Casanova, Yanick J Crow, Bénédicte Manoury, Marie-Louise Frémond, Jonathan Bohlen, Alice Lepelley
Gain-of-function human UNC93B1 variants cause systemic lupus erythematosus and chilblain lupus. The Journal of experimental medicine 221 (8) (2024)
Fanny C Kpenou, Carle F Paul, Julien Seneschal, Nicolas Andreu, Sébastien Barbarot, Marie Tauber, Pierre-André Natella, Jason Shourick, Khaled Ezzedine
The Atopic Dermatitis Patient Journey: Insights from a Qualitative Study. The British journal of dermatology (2024)
Clémence David, Carlos A Arango-Franco, Mihaly Badonyi, Julien Fouchet, Gillian I Rice, Blaise Didry-Barca, Lucie Maisonneuve, Luis Seabra, Robin Kechiche, Cecile Masson, Aurélie Cobat, Laurent Abel, Estelle Talouarn, Vivien Béziat, Caroline Deswarte, Katie Livingstone, Carle F Paul, Gulshan Malik, Alison Ross, Jane Adam, Jo Walsh, T Sathish Kumar, Damien Bonnet, Christine Bodemer, Brigitte Bader-Meunier, Joseph A Marsh, Jean Laurent Casanova, Yanick J Crow, Bénédicte Manoury, Marie-Louise Frémond, Jonathan Bohlen, Alice Lepelley
Gain-of-function human UNC93B1 variants cause systemic lupus erythematosus and chilblain lupus. The Journal of experimental medicine 221 (8) (2024)
Alessia Baldo, Jeremy Di Domizio, Ahmad Yatim, Sophie Vandenberghe-Dürr, Raphael Jenelten, Anissa Fries, Lorenzo Grizzetti, François Kuonen, Carle F Paul, Robert L Modlin, Curdin Conrad, Michel Gilliet
Human neutrophils drive skin autoinflammation by releasing interleukin (IL)-26. The Journal of experimental medicine 221 (5) (2024)
Clémence David, Carlos A Arango-Franco, Mihaly Badonyi, Julien Fouchet, Gillian I Rice, Blaise Didry-Barca, Lucie Maisonneuve, Luis Seabra, Robin Kechiche, Cecile Masson, Aurélie Cobat, Laurent Abel, Estelle Talouarn, Vivien Béziat, Caroline Deswarte, Katie Livingstone, Carle F Paul, Gulshan Malik, Alison Ross, Jane Adam, Jo Walsh, T Sathish Kumar, Damien Bonnet, Christine Bodemer, Brigitte Bader-Meunier, Joseph A Marsh, Jean Laurent Casanova, Yanick J Crow, Bénédicte Manoury, Marie-Louise Frémond, Jonathan Bohlen, Alice Lepelley
Gain-of-function human UNC93B1 variants cause systemic lupus erythematosus and chilblain lupus. The Journal of experimental medicine 221 (8) (2024)
Alessia Baldo, Jeremy Di Domizio, Ahmad Yatim, Sophie Vandenberghe-Dürr, Raphael Jenelten, Anissa Fries, Lorenzo Grizzetti, François Kuonen, Carle F Paul, Robert L Modlin, Curdin Conrad, Michel Gilliet
Human neutrophils drive skin autoinflammation by releasing interleukin (IL)-26. The Journal of experimental medicine 221 (5) (2024)
Alessia Baldo, Jeremy Di Domizio, Ahmad Yatim, Sophie Vandenberghe-Dürr, Raphael Jenelten, Anissa Fries, Lorenzo Grizzetti, François Kuonen, Carle F Paul, Robert L Modlin, Curdin Conrad, Michel Gilliet
Human neutrophils drive skin autoinflammation by releasing interleukin (IL)-26. The Journal of experimental medicine 221 (5) (2024)
Clémence David, Carlos A Arango-Franco, Mihaly Badonyi, Julien Fouchet, Gillian I Rice, Blaise Didry-Barca, Lucie Maisonneuve, Luis Seabra, Robin Kechiche, Cecile Masson, Aurélie Cobat, Laurent Abel, Estelle Talouarn, Vivien Béziat, Caroline Deswarte, Katie Livingstone, Carle F Paul, Gulshan Malik, Alison Ross, Jane Adam, Jo Walsh, T Sathish Kumar, Damien Bonnet, Christine Bodemer, Brigitte Bader-Meunier, Joseph A Marsh, Jean Laurent Casanova, Yanick J Crow, Bénédicte Manoury, Marie-Louise Frémond, Jonathan Bohlen, Alice Lepelley
Gain-of-function human UNC93B1 variants cause systemic lupus erythematosus and chilblain lupus. The Journal of experimental medicine 221 (8) (2024)
Mark Lebwohl, Richard Bruce Warren, Howard Sofen, Shinichi Imafuku, Carle F Paul, Jacek Cezary Szepietowski, Lynda Spelman, Thierry Passeron, Eleni Vritzali, Andrew Napoli, Renata M Kisa, Alex Buck, Subhashis Banerjee, Diamant Thaҫi, Andrew Blauvelt
Deucravacitinib in plaque psoriasis: 2-year safety and efficacy results from the phase 3 poetyk trials. The British journal of dermatology (2024)
Richard G Langley, Howard Sofen, Ignacio Dei-Cas, Kristian Reich, Bardur Sigurgeirsson, Richard Bruce Warren, Carle F Paul, Jacek Cezary Szepietowski, Tsen Fang Tsai, Isabelle Hampele, Ruquan You, Pascal Charef, Charis Papavassilis
Secukinumab long-term efficacy and safety in psoriasis through to year 5 of treatment: results of a randomized extension of the phase III ERASURE and FIXTURE trials. The British journal of dermatology 188 (2) (2023)
Marie Tauber, Lilian Basso, Jeremy Martin, Luciana E Bostan, Marlene Magalhaes Pinto, Guilhem R Thierry, Raïssa Houmadi, Nadine Serhan, Alexia Loste, Camille Blériot, Jasper B J Kamphuis, Mirjana Grujic, Lena Kjellén, Gunnar Pejler, Carle F Paul, Xinzhong Dong, Stephen J Galli, Laurent Lionel Reber, Florent Ginhoux, Marc Bajenoff, Rebecca Gentek, Nicolas Gaudenzio
Landscape of mast cell populations across organs in mice and humans. The Journal of experimental medicine 220 (10) (2023)
Bruce E Strober, Yayoi Tada, Ulrich Mrowietz, Mark Lebwohl, Peter Foley, Richard G Langley, Richard Bruce Warren, Maggie Wang, Veerle Vanvoorden, Balint Szilagyi, Valerie Ciaravino, Carle F Paul
Bimekizumab maintenance of response through three years in patients with moderate to severe plaque psoriasis: Results from the BE BRIGHT open-label extension trial. The British journal of dermatology (2023)
Richard G Langley, Howard Sofen, Ignacio Dei-Cas, Kristian Reich, Bardur Sigurgeirsson, Richard Bruce Warren, Carle F Paul, Jacek Cezary Szepietowski, Tsen Fang Tsai, Isabelle Hampele, Ruquan You, Pascal Charef, Charis Papavassilis
Secukinumab long-term efficacy and safety in psoriasis through to year 5 of treatment: results of a randomized extension of the phase III ERASURE and FIXTURE trials. The British journal of dermatology 188 (2) (2023)
Hélène Aubert, Hugo Arlegui, Yann De Rycke, Herve Bachelez, Marie Beylot-Barry, Alain Dupuy, Pascal Joly, Denis Jullien, Emmanuel Mahé, Carle F Paul, Marie-Aleth Richard, Emilie Sbidian, Manuelle Viguier, Olivier Chosidow, Florence Tubach, Nathalie Bénéton, null null
Biologic tapering for patients with psoriasis with low disease activity: data from the French PsoBioTeq Registry. The British journal of dermatology 188 (1) (2023)
Romain Salle, Florence Tubach, Hugo Arlegui, Raphaëlle Curmin, Manuelle Viguier, Marie Beylot-Barry, Alain Dupuy, Nathalie Beneton, Pascal Joly, Yann De Rycke, Denis Jullien, Emmanuel Mahé, Carle F Paul, Marie-Aleth Richard, Herve Bachelez, Marilyn Zago, Olivier Chosidow, Emilie Sbidian, null null
Clinical features, therapeutic choice and response by phototype in psoriasis: analysis of the French PsoBioTeq cohort. Clinical and experimental dermatology (2023)
Bruce E Strober, Yayoi Tada, Ulrich Mrowietz, Mark Lebwohl, Peter Foley, Richard G Langley, Richard Bruce Warren, Maggie Wang, Veerle Vanvoorden, Balint Szilagyi, Valerie Ciaravino, Carle F Paul
Bimekizumab maintenance of response through three years in patients with moderate to severe plaque psoriasis: Results from the BE BRIGHT open-label extension trial. The British journal of dermatology (2023)
Carle F Paul
The use of large patient databases to improve disease understanding and care. The British journal of dermatology 187 (5) (2022)
Alexis Barranca, Sébastien Debarbieux, Emmanuelle Tancrède-Bohin, Clémence Saillard, Bruno Sassolas, Sophie Voisin, Françoise Fortenfant, Chloe Bost, Ségolène Claeyssens-Donadel, Pascal Joly, Christophe Bedane, Cristina Bulai-Livideanu, Carle F Paul, Maria-Polina Konstantinou
A nationwide study evaluating the association of autoimmune bullous diseases and acquired haemophilia: description of clinical and prognostic features. The British journal of dermatology 186 (5) (2022)
Anna Kychygina, Myriam Cassagne, Marie Tauber, Stéphane Galiacy, Carle F Paul, Pierre Fournie, Michel Simon
Dupilumab-Associated Adverse Events During Treatment of Allergic Diseases. Clinical reviews in allergy & immunology 62 (3) (2022)
Lluis L Puig, Antonio Costanzo, Ernesto J Muñoz-Elías, Maria Jazra, Sven Wegner, Carle F Paul, Curdin Conrad
The biological basis of disease recurrence in psoriasis: a historical perspective and current models. The British journal of dermatology 186 (5) (2022)
Thomas Bieber, Kristian Reich, Carle F Paul, Yuichiro Tsunemi, Matthias Augustin, Jean-Philippe Lacour, Pierre-Dominique Ghislain, Yves Dutronc, Ran Liao, Fan E Yang, Dennis Brinker, Amy M DeLozier, Eric Meskimen, Jonathan M Janes, Kilian Eyerich, null null
Efficacy and safety of baricitinib in combination with topical corticosteroids in patients with moderate-to-severe atopic dermatitis with inadequate response, intolerance or contraindication to ciclosporin: results from a randomized, placebo-controlled, phase III clinical trial (BREEZE-AD4). The British journal of dermatology 187 (3) (2022)
Fatma Jendoubi, Jason Shourik, Julien Seneschal, Francoise Giordano-Labadie, Nadia Raison-Peyron, Aurélie Du-Thanh, Florence Tetart, Aude Valois, Catherine Droitcourt, Aude Clément, Audrey Nosbaum, Marie Noelle Crepy, Marie Jachiet, Jean David Bouaziz, Claire Bernier, Angele Soria, Carle F Paul, Sébastien Barbarot, Marie Tauber, null null
Longer dupilumab dosing intervals in adult patients with atopic dermatitis: experience from a French multicentre retrospective cohort study. The British journal of dermatology 187 (4) (2022)
Marie Beylot-Barry, Julien Seneschal, D Tran, Herve Bachelez, N Beneton, A Dupuy, P Joly, Denis Jullien, Emmanuel Mahé, Carle F Paul, Marie Aleth Richard, Emilie Sbidian, M Viguier, Olivier Chosidow, F Tubach
Characteristics of patients with psoriasis with Psoriasis Area and Severity Index < 10 treated with biological agents: results from the French PsoBioTeq cohort. The British journal of dermatology 185 (5) (2021)
Dedee Frances Murrell, Carle F Paul
What instruments should we add to our toolbox for measuring the severity and control of eczema? The British journal of dermatology 185 (1) (2021)
Andrew Blauvelt, April W Armstrong, Richard G Langley, Kurt Gebauer, Diamant Thaҫi, Jerry Bagel, Lyn C Guenther, Carle F Paul, Bruce Randazzo, Susan Flavin, Ming-Chun Hsu, Yin You, Kristian Reich
Efficacy of guselkumab versus secukinumab in subpopulations of patients with moderate-to-severe plaque psoriasis: results from the ECLIPSE study. The Journal of dermatological treatment (2021)
F Jendoubi, J Shourick, M Negretto, C Laurent, P A Apoil, S Evrard, V Mansat-De Mas, M Severino-Freire, C Mailhol, Y Degboé, P Dubreuil, O Hermine, Carle F Paul, Cristina Bulai-Livideanu
Cutaneous mastocytosis in adults with a serum tryptase level < 20 ng mL-1 : why we should investigate further. The British journal of dermatology 185 (2) (2021)
Andrew Blauvelt, Carle F Paul, Peter Cornelis Maria van de Kerkhof, R B Warren, A B Gottlieb, R G Langley, F Brock, C Arendt, M Boehnlein, M Lebwohl, Kristian Reich
Long-term safety of certolizumab pegol in plaque psoriasis: pooled analysis over 3 years from three phase III, randomized, placebo-controlled studies. The British journal of dermatology 184 (4) (2020)
R B Warren, Andrew Blauvelt, Y Poulin, S Beeck, M Kelly, T Wu, Z Geng, Carle F Paul
Efficacy and safety of risankizumab vs. secukinumab in patients with moderate-to-severe plaque psoriasis (IMMerge): results from a phase III, randomized, open-label, efficacy-assessor-blinded clinical trial. The British journal of dermatology 184 (1) (2020)
Marie Tauber, P A Apoil, Camile Richet, J Laurent, G De Bonnecaze, E Mouchon, M Cassagne, M C Marguery, S Hegazy, M P Konstantinou, M Severino, C Uthurriague, F Giordano-Labadie, A Didier, Carle F Paul
Effect of dupilumab on atopic manifestations in patients treated for atopic dermatitis in real-life practice. The British journal of dermatology 180 (6) (2019)
Kristian Reich, L Puig, J C Szepietowski, Carle F Paul, J P Lacour, A Tsianakas, C Sieder, M Rissler, E Pournara, R Orsenigo
Secukinumab dosing optimization in patients with moderate-to-severe plaque psoriasis: results from the randomized, open-label OPTIMISE study. The British journal of dermatology 182 (2) (2019)
Carle F Paul
Ixekizumab or secukinumab in psoriasis: what difference does it make? The British journal of dermatology 178 (5) (2019)
L Ferrières, M P Konstantinou, Cristina Bulai-Livideanu, S Hegazy, M Tauber, F Amelot, Carle F Paul
Long-term continuation with secukinumab in psoriasis: association with patient profile and initial psoriasis clearance. Clinical and experimental dermatology 44 (7) (2019)
Cristina Bulai-Livideanu, M Severino-Freire, F Jendoubi, E Tournier, T Commont, O Hermine, Carle F Paul
Image Gallery: The vulva: an atypical localization of mastocytosis in adulthood. The British journal of dermatology 181 (2) (2019)
Kim A Papp, C L Leonardi, Andrew Blauvelt, Kristian Reich, N J Korman, M Ohtsuki, Carle F Paul, S Ball, G S Cameron, J Erickson, L Zhang, L Mallbris, C E M Griffiths
Ixekizumab treatment for psoriasis: integrated efficacy analysis of three double-blinded, controlled studies (UNCOVER-1, UNCOVER-2, UNCOVER-3). The British journal of dermatology 178 (3) (2018)
Francesca Sampogna, Lluis L Puig, P Spuls, G Girolomoni, M A Radtke, B Kirby, M Brunori, P Bergmans, P Smirnov, J Rundle, A Castiglia, F Lavie, Carle F Paul
Reversibility of alexithymia with effective treatment of moderate-to-severe psoriasis: longitudinal data from EPIDEPSO. The British journal of dermatology 180 (2) (2018)
G Salomon, A Maza, S Boulinguez, Carle F Paul, L Lamant, E Tournier, J Mazereeuw-Hautier, Nicolas Meyer
Efficacy of anti-programmed cell death-1 immunotherapy for skin carcinomas and melanoma metastases in a patient with xeroderma pigmentosum. The British journal of dermatology 178 (5) (2018)
Mads Almose Røpke, Cristina Bulai-Livideanu, R Kaldate, A Snel, Carle F Paul
Changes in interleukin-17A, macrophage-derived chemokine and adiponectin following treatment of psoriasis with calcipotriol plus betamethasone dipropionate aerosol foam: results from the PSO-ABLE study. The British journal of dermatology 178 (1) (2017)
Kristian Reich, A Pinter, J P Lacour, C Ferrandiz, G Micali, L E French, M Lomaga, Y Dutronc, C Henneges, S Wilhelm, S Hartz, Carle F Paul, null null
Comparison of ixekizumab with ustekinumab in moderate-to-severe psoriasis: 24-week results from IXORA-S, a phase III study. The British journal of dermatology 177 (4) (2017)
M Aleissa, M P Konstantinou, Mahtab Samimi, L Lamant, P Gaboriaud, A Touze, C Ceppi, Cristina Bulai-Livideanu, Carle F Paul
Trichodysplasia spinulosa associated with HIV infection: clinical response to acitretin and valganciclovir. Clinical and experimental dermatology 43 (2) (2017)